URAC Launches First-Ever Health Care AI Accreditation Program
New program sets national standards for ethical and trustworthy AI use in patient care WASHINGTON, Sept. 15, 2025 /PRNewswire/ --...
Year: 2025
Frank Montes De Oca and John Wagner Join the Assistance Fund’s Board of Directors
ORLANDO, FL / ACCESS Newswire / September 15, 2025 / The Assistance Fund (TAF), an independent charitable patient assistance organization...
PAO Group Inc Announces New CEO James Schramm
OMAHA, NE / ACCESS Newswire / September 15, 2025 / PAO Group, Inc. (OTC:PAOG), today announced the appointment of James...
Protagonist Announces Icotrokinra Phase 2b ANTHEM-UC Trial Data to be Presented at the United European Gastroenterology Week Berlin 2025
NEWARK, CALIFORNIA / ACCESS Newswire / September 15, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that data...
NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical’s Intellectual Property Portfolio
Latest patent award strengthens competitive moat and reinforces leadership in medical navigation technologyTYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or...
Modular Medical Receives IRB Approval for Pivot Insulin Delivery System Feasibility Study
-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September...
International Health Insurers to Invest USD 65 Billion in Core IT by 2027
Black Book Insights' global survey of 404 executives across 40 countries forecasts USD 65 billion in annual non-U.S. payer IT...
Berry Street Launches GLP-1 Nutrition Pathway Program
New Comprehensive Program Supports Patients Throughout Entire GLP-1 JourneyNEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Berry Street, an AI-powered...
Botany Scientifics Wins “Top Full Spectrum Hemp Products 2025” Award from Cannabis Business Insights Magazine
Texas hemp company recognized for exceptional quality, precision dosing, and pioneering consumer educationSAN ANTONIO, Sept. 15, 2025 (GLOBE NEWSWIRE) --...
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million...
Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease
Current XanaMIA pivotal phase 2/3 trial on track for interim analysis in January 2026 and final results late 2026 with...
ObservSMART Surpasses 2 Billion Patient Observations
PHILADELPHIA, Sept. 15, 2025 /PRNewswire/ -- InvisALERT Solutions' ObservSMART, the industry-leading proximity-required technology designed to improve staff and patient safety...
MGI Tech Introduces DNBSEQ-T7+: A Next-Generation ‘Data Mining Machine’ for Genomics
SHENZHEN, China, Sept. 14, 2025 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and...
LASIK.com Launches Collegiate NIL Program to Help Student‑Athletes Compete and Live With Clearer Vision
Nationwide initiative pairs eligible college athletes with trusted LASIK surgeons and a compliant, content‑first partnership model AUSTIN, TX / ACCESS...
Kerr Announces the Launch of SimpliCore(TM) Gutta Percha Carrier Obturators for Simplified Endodontics
BREA, CALIFORNIA / ACCESS Newswire / September 15, 2025 / Kerr is excited to announce the launch of SimpliCore™, a...
President Trump Clears the Path for Medical Marijuana Reform – Now Will DEA’s Terry Cole Act?
"By throwing out the DEA's Biden marijuana mess, President Trump opened the door for real medicine - MMJ's FDA cannabis...
Lindis Blood Care Announces Publication of Final Results from Pivotal REMOVE Study with CATUVAB(R) in the Journal of Clinical Anesthesia
Primary endpoint met, demonstrating depletion of EpCAM (epithelial cell adhesion molecule)-positive cancer cells from intraoperatively salvaged blood (p<0,0001)All safety endpoints,...
BioNxt Advances Semaglutide Oral Dissolvable Film (ODF) Program with Successful Proof-of-Concept and Prototype Development
VANCOUVER, BC / ACCESS Newswire / September 15, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT) is pleased...
Genflow Signs CDAs with Animal Health Companies
Genflow Signs CDAs with Animal Health Companies to Advance Longevity Gene Therapy Platform LONDON, UK / ACCESS Newswire / September...
Armor Health Announces Partnership with Antidote-AI to Revolutionize Correctional Healthcare Landscape
MIAMI, Sept. 14, 2025 /PRNewswire/ -- Armor Health (ArmorHealthcare.com), today announced it's new partnership with Antidote-AI (Antidote-AI.com) as their correctional...